You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Locally Advanced Colorectal Cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Colon Cancer, Neoadjuvant Therapy, Immunotherapy Trial in Guangzhou (Envafolimab, CAPEOX)

Recruiting
  • Colon Cancer
  • +2 more
  • Guangzhou, Guangdong, China
    Sun Yat-Sen University Cancer Center
Aug 26, 2023

Locally Advanced Colorectal Cancer Trial (Capecitabine, Oxaliplatin, Bevacizumab)

Not yet recruiting
  • Locally Advanced Colorectal Cancer
  • (no location specified)
Oct 18, 2022

Locally Advanced Colorectal Carcinoma Trial in Beijing (Cadonilimab, FOLFOX regimen)

Recruiting
  • Locally Advanced Colorectal Carcinoma
  • Beijing, Beijing, China
    Cancer Hospital/ National Cancer Center, Chinese Academy of Medi
Nov 23, 2023

Colorectal Cancer Trial in Guangzhou (mFOLFOXIRI + Cadonilimab, mFOLFOX6)

Not yet recruiting
  • Colorectal Cancer
  • Guangzhou, Guangdong, China
    Gastrointestinal Hospital, Sun Yat-sen University
Oct 17, 2022

Immunotherapy in Advanced or Locally Advanced dMMR/MSI-H

Recruiting
  • Colorectal Cancer
    • Shanghai, China
      Fudan University Shanghai Cancer Center
    Oct 18, 2023

    dMMR Colorectal Cancer Trial in Beijing (Cadonilimab)

    Recruiting
    • dMMR Colorectal Cancer
    • Beijing, Beijing, China
      National Cancer Center/Cancer Hospital, Chinese Academy of Medic
    Apr 13, 2023

    Colorectal Cancer Trial (Pembrolizumab)

    Recruiting
    • Colorectal Cancer
    • Amsterdam, Netherlands
      Netherlands Cancer Institute
    Jan 3, 2023

    DMMR Colorectal Cancer, MSI-H Colorectal Cancer, Locally Advanced Colorectal Cancer Trial in Guangzhou (drug, radiation,

    Recruiting
    • DMMR Colorectal Cancer
    • +2 more
    • PD-1 Antibody
    • +4 more
    • Guangzhou, Guangdong, China
      Sun Yat-sen University Cancer Center
    Sep 22, 2021

    Esophageal Cancer, Gastric Cancer, Colorectal Cancer Trial in Beijing (SI-B003, BL-B01D1)

    Not yet recruiting
    • Esophageal Cancer
    • +2 more
    • Beijing, Beijing, China
      Beijing Cancer Hospital
    Aug 22, 2023

    Colorectal Cancer Trial (Serplulimab + FOLFOXIRI, Radiation therapy)

    Not yet recruiting
    • Colorectal Cancer
    • Serplulimab + FOLFOXIRI
    • Radiation therapy
    • (no location specified)
    Oct 24, 2023

    Neoadjuvant Chemoradiotherapy Combined With PD-1 Inhibitor and

    Not yet recruiting
    • Colorectal Neoplasms
    • Beijing, Xicheng Dis, China
      Beijing Friendship Hospital, Capital medical University
    Sep 5, 2023

    Cancer, Colorectal Cancer, Solid Tumor Trial in San Antonio (FOG-001)

    Recruiting
    • Cancer
    • +11 more
    • San Antonio, Texas
      South Texas Accelerated Research Therapeutics, LLC
    Jun 21, 2023

    Unresectable Locally Advanced Colorectal Cancer, Metastatic Colorectal Cancer, Candidate for Third-line Treatment or Subsequent

    Not yet recruiting
    • Unresectable Locally Advanced Colorectal Cancer
    • +2 more
    • Blood Sample Collection
    • Anderlecht, Belgium
    • +5 more
    Aug 2, 2022

    High-risk Locally Advanced Colorectal Cancer, Neoadjuvant Chemo, FOLFOXIRI Regimen Trial in Chengdu (Oxaliplatin, Irinotecan,

    Recruiting
    • High-risk Locally Advanced Colorectal Cancer
    • +2 more
    • Chengdu, Sichuan, China
      Sichuan University West China Hospital
    Aug 18, 2021

    Colorectal Cancer Stage II, Colorectal Cancer Stage III, Mmr Deficiency Trial in Guangzhou (drug, radiation, procedure, other)

    Active, not recruiting
    • Colorectal Cancer Stage II
    • Colorectal Cancer Stage III
    • Guangzhou, Guangdong, China
      Medical Oncology,Sun Yat-sen University Cancer Center
    Jan 29, 2023

    Colorectal Cancer, NSCLC Trial (GDC-1971, Osimertinib, Cetuximab)

    Not yet recruiting
    • Colorectal Cancer
    • Non-Small Cell Lung Cancer
    • (no location specified)
    Jul 12, 2023

    Colorectal Cancer Trial in Beijing (IBI310 (anti-CTLA-4 antibody), Sintilimab(anti-PD-1 antibody))

    Active, not recruiting
    • Colorectal Cancer
    • IBI310 (anti-CTLA-4 antibody)
    • Sintilimab(anti-PD-1 antibody)
    • Beijing, China
      Beijing cancer hospital
    Sep 15, 2022

    Colorectal Cancer, Microsatellite Instability High Trial in Guangzhou (PD-1 inhibitor plus VEGF inhibitors)

    Recruiting
    • Colorectal Cancer
    • Microsatellite Instability High
    • PD-1 inhibitor plus VEGF inhibitors
    • Guangzhou, Guangdong, China
      651 Dongfeng Road East
    May 27, 2022

    Colorectal Cancer Trial in Australia, Spain, United States (BLYG8824A)

    Recruiting
    • Colorectal Cancer
    • Duarte, California
    • +5 more
    Aug 2, 2022

    Melanoma, Urothelial Carcinoma, Renal Cell Carcinoma Trial in Auchenflower (RC198 Injection)

    Not yet recruiting
    • Melanoma
    • +5 more
    • RC198 Injection
    • Auchenflower, Queensland, Australia
      Research Site
    May 17, 2023

    Cancer, Tumor, Solid, Advanced Solid Tumor Trial in Brussels, Barcelona, Madrid (JK08)

    Recruiting
    • Cancer
    • +6 more
    • Brussels, Belgium
    • +3 more
    Jan 30, 2023

    Rectal Cancer Trial in Guangzhou (Sintilimab)

    Recruiting
    • Rectal Cancer
    • Guangzhou, Guangdong, China
      Department of colorectal surgery, the Sixth Affiliated Hospital,
    Jul 11, 2022

    Cancer, Solid Tumor, Colorectal Cancer Trial (biological, radiation, drug)

    Not yet recruiting
    • Cancer
    • +8 more
    • DK210 (EGFR)
    • +3 more
    • (no location specified)
    Jan 27, 2023

    Preoperative Neoadjuvant Chemoradiotherapy Combined PD-1

    Recruiting
    • Colorectal Neoplasms
    • long course radiotherapy + capecitabine + PD-1 monoclonal antibody
    • Beijing, Beijing, China
      Beijing Friendship Hospital
    May 5, 2022

    Colorectal Carcinoma Trial (Pembrolizumab)

    Completed
    Has Results
    • Colorectal Carcinoma
    • Pembrolizumab
    • (no location specified)
    Mar 29, 2022